Perioperative medicine & outcomes

IMpact of PerioperAtive KeTamine on Enhanced Recovery After abdominal Surgery (IMPAKT enhanced recovery after surgery (ERAS)): a pragmatic randomised single-cluster trial

Br J AnaesthPublished Randomised controlled trial

Primary result · Hospital LOSResult — go to the resultOdds ratio 1.21 95% CI 1.00–1.47

Authors' conclusion

The addition of ketamine to a multimodal abdominal ERAS protocol provided no significant benefits and was associated with worse perioperative outcomes.

Study context

Population
Adults (≥18 yr) undergoing major abdominal surgery within an established ERAS protocol
Participants
1,522 adults
Comparison
Ketamine vs saline placebo
Primary endpoint
Hospital LOS
Methodological detailspragmatic, double-blind, placebo-controlled, single-cluster
  • Pragmatic
  • Double-blind
  • Placebo-controlled
  • Single-cluster

Primary result

As reported in the abstract

Odds ratio

1.21

95% CI 1.00–1.47

Ketamine vs Placebo
OR 1.21 (95% CI 1.00–1.47)

Secondary outcomes

OutcomeOR (95% CI)
Opioid consumptionDid not decrease opioid consumption · covariate adjusted analyses0.85 (0.71–1.01)
Meeting early discharge milestonesLower odds with ketamine0.68 (0.50–0.93)

Safety

OutcomeOR (95% CI)
ICU transferHigher odds with ketamine2.03 (1.14–3.63)
Debilitating dizzinessHigher rates with ketamine6.05 (3.02–12.11)
Debilitating hallucinationsHigher rates with ketamine2.69 (1.09–6.65)
Other severe side-effectsHigher rates with ketamine1.94 (1.27–2.96)

Rapid response activation

Similar between groups
OR 1.51; 95% CI 0.85-2.68

Ileus requiring nasogastric decompression

Similar between groups
OR 1.26; 95% CI 0.87-1.84

Original publication

IMpact of PerioperAtive KeTamine on Enhanced Recovery After abdominal Surgery (IMPAKT ERAS): a pragmatic randomised single-cluster trial. Br J Anaesth. Published 3 September 2025. doi:10.1016/j.bja.2025.08.001

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.